Загрузка...
Oritavancin Combinations with β-Lactams against Multidrug-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococci
Oritavancin possesses activity against vancomycin-resistant enterococci (VRE) and methicillin-resistant Staphylococcus aureus (MRSA). In vitro data suggest synergy between beta-lactams (BLs) and vancomycin or daptomycin, agents similar to oritavancin. We evaluated the activities of BLs combined with...
Сохранить в:
| Опубликовано в: : | Antimicrob Agents Chemother |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
American Society for Microbiology
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4808215/ https://ncbi.nlm.nih.gov/pubmed/26833159 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.03006-15 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|